Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

• COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

Detalles Bibliográficos
Autores principales: Galeano-Valle, F., Oblitas, C.M., Ferreiro-Mazón, M.M., Alonso-Muñoz, J., del Toro-Cervera, J., di Natale, M., Demelo-Rodríguez, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227496/
https://www.ncbi.nlm.nih.gov/pubmed/32425261
http://dx.doi.org/10.1016/j.thromres.2020.05.017
Descripción
Sumario:• COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. • Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. • Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

Ejemplares similares